5 listed pharmas can’t even pay interest payable from earnings

5 listed pharmaceutical companies including Cho-A Pharm and Samsung Pharm were observed to be financially difficult to even pay interests of their debts from earnings, showing a poor ability to pay debts.

6 companies including Whanin Pharm, Reyon Pharmaceutical and Ilsung Pharmaceuticals, on the contrary, manage their company barely with interests of debts.

Yakup Shinmoon(www.yakup.com) analy...